Caffeine and Resistance Training, CYP1A2 Polymorphism
Conditions
Brief summary
Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, it remains to be elucidated how CYP1A2 polymorphism influences the prolonged effects of caffeine on this type of exercise. Objectives: The present study aims to analyze the prolonged effects of caffeine intake on neuromuscular adaptations to resistance training according to CYP1A2 polymorphism in men and women.
Interventions
DIETARY_SUPPLEMENTCaffeine and Resistance training
Acute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.
DIETARY_SUPPLEMENTPlacebo and Resistance training
Acute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.
Sponsors
University of Alcala
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Masking description
Statistician
Eligibility
Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Age between ≥ 18 and ≤ 35 years. * Body mass index (BMI) lowe than 25 kg/m². * Physically active subjects (≥ 150 min/week of moderate exercise). * Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from performing physical exercise. * Participants capable of performing the tests.
Exclusion criteria
* History of neuromuscular, cardiac, or diseases that could affect liver or muscle metabolism. * Use of drugs or other stimulants that interfere with caffeine intake and intestinal absorption during the tests and study. * Body mass index (BMI) ≥ 25 kg/m². * Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study. * Performing strenuous exercise within 48 hours prior to the tests. * Failing to replicate the same food intake on the two experimental days. * Consuming caffeine after 6 PM on the day prior to training or testing.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean velocity at different %1RM | Through study completion, an average of 12 weeks | Measuring bar mean velocity desplacement during bench press and back squat exercises. |
| Peak velocity at different %1RM | Through study completion, an average of 12 weeks | Measuring bar peak velocity and time to reach peak velocity of bar desplacement during bench press and back squat exercises. |
| Mean power output at different %1RM | Through study completion, an average of 12 weeks | Measuring during bench press and back squat exercises. |
| Peak power output and time to reach peak power output at different %1RM | Through study completion, an average of 12 weeks | Measuring during bench press and back squat exercises. |
| Number of repetitions performed at 65%1RM until task failure | Through study completion, an average of 12 weeks | In bench press and back squat exercises |
| Bar velocity deplacement performed in 1 set at 65%1RM until task failure | Through study completion, an average of 12 weeks | In bench press and back squat exercises |
| Power output generated in 1 set at 65%1RM until task failure | Through study completion, an average of 12 weeks | In bench press and back squat exercise |
| Resting Metabolic Rate (RMR) | Through study completion, an average of 12 weeks | Kcal at rest using a metabolic chart. |
| Maximal Fat Oxidation Rate (MFO) | Through study completion, an average of 12 weeks | g/min (MFO) using a metabolic chart. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fat-free mass | Through study completion, an average of 4 weeks | Using electrical bioimpedance and untrasound in the quadriceps muscle |
| Fat mass | Through study completion, an average of 12 weeks | Using electrical bioimpedance (kg and % of body mass) |
| Physical activity (METs-min/wk) | Through study completion, an average of 12 weeks | Using IPAQ |
| Dietary (g/kg of macronutrients) | Through study completion, an average of 12 weeks | Using a 24-total recall |
| Mood state | Through study completion, an average of 12 weeks | Participants graded a set of 29 items related to the mood on a Likert scale from 0 (not at all) to 4 (extremely) in reply to the question;How do you feel at this moment?; to assess six scales: tension, depression, anger, vigor, fatigue and confusion. |
| Adverse effects | Through study completion, an average of 12 weeks | Adverse effects. perception of power, endurance, energy and exertion, as well as heart, muscular and gastrointestinal discomfort. |
Countries
Spain
Outcome results
None listed